Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report in: Neurosurgical Focus Volume 50 Issue 2 (2021) Journals
![Taking on Glioblastoma Through Translational Research: 4 Promising Bench-to-Bedside Initiatives – Consult QD Taking on Glioblastoma Through Translational Research: 4 Promising Bench-to-Bedside Initiatives – Consult QD](https://3pw8zx30ta4c3jegjv14ssuv-wpengine.netdna-ssl.com/wp-content/uploads/sites/2/2018/11/18-NEU-4915-Ahluwalia-Pathways-Graph.jpg)
Taking on Glioblastoma Through Translational Research: 4 Promising Bench-to-Bedside Initiatives – Consult QD
![Tumour treating fields therapy for glioblastoma: current advances and future directions | British Journal of Cancer Tumour treating fields therapy for glioblastoma: current advances and future directions | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-01136-5/MediaObjects/41416_2020_1136_Fig1_HTML.png)
Tumour treating fields therapy for glioblastoma: current advances and future directions | British Journal of Cancer
![Immunotherapy and Glioblastoma: Assessing Strategies to Harness the Immune System Across a Range of Trials – Consult QD Immunotherapy and Glioblastoma: Assessing Strategies to Harness the Immune System Across a Range of Trials – Consult QD](https://3pw8zx30ta4c3jegjv14ssuv-wpengine.netdna-ssl.com/wp-content/uploads/sites/2/2016/09/16-NEU-1934-Ahluwalia-Inset.jpg)
Immunotherapy and Glioblastoma: Assessing Strategies to Harness the Immune System Across a Range of Trials – Consult QD
![Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy - ScienceDirect Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517320302672-ga1.jpg)